The prevalence of inherited thrombophilic polymorphisms in an asymptomatic Australian antenatal population

Aim: Inherited thrombophilic polymorphisms have been linked to pregnancy-related thromboembolism and other adverse pregnancy outcomes. As there are limited data on the prevalence of these polymorphisms in Australian populations, we aimed to assess this in an antenatal population. Methods: Healthy nu...

Full description

Bibliographic Details
Main Authors: Said, J., Brennecke, S., Moses, Eric, Walker, S., Monagle, P., Campbell, J., Bryant, V., Borg, A., Higgins, J.
Format: Journal Article
Published: Wiley-Blackwell Publishing Asia 2008
Online Access:http://hdl.handle.net/20.500.11937/35550
_version_ 1848754526925881344
author Said, J.
Brennecke, S.
Moses, Eric
Walker, S.
Monagle, P.
Campbell, J.
Bryant, V.
Borg, A.
Higgins, J.
author_facet Said, J.
Brennecke, S.
Moses, Eric
Walker, S.
Monagle, P.
Campbell, J.
Bryant, V.
Borg, A.
Higgins, J.
author_sort Said, J.
building Curtin Institutional Repository
collection Online Access
description Aim: Inherited thrombophilic polymorphisms have been linked to pregnancy-related thromboembolism and other adverse pregnancy outcomes. As there are limited data on the prevalence of these polymorphisms in Australian populations, we aimed to assess this in an antenatal population. Methods: Healthy nulliparous women (n=2031) were recruited to this study. The women had no past or family history of venous thromboembolism. Women were excluded if they or a family member was known to be a carrier of any thrombophilic marker. Genotyping from venous blood for the factor V Leiden, prothrombin 20210A, MTHFR 611 and 1298 and thrombomodulin C1418T polymorphisms was undertaken. Results: Key findings were that 101 of 2019 (5.30, 95% confidence interval 4.36-6.31%) women tested were heterozygous carriers of factor V Leiden and one was homozygous (0.05, 0-0.21%); 2.43% of women were heterozygous carriers of the prothrombin gene mutation (1.80-3.20%) while no women were homozygous for this mutation; 11.62% (10.22-13.02%) and 9.98% (8.61-11.29%) were homozygous for the MTHFR 611 and 1298 polymorphisms, respectively, and 3.43% (2.63-4.22%) of women were homozygous for the thrombomodulin polymorphism. Conclusions: The prevalence of these polymorphisms is consistent with previously published data in Caucasian populations. These data will provide the basis for further assessment of the relationship between poor pregnancy outcome and these inherited thrombophilic polymorphisms in an asymptomatic antenatal population. © 2008 The Royal Australian and New Zealand College of Obstetricians and Gynaecologists.
first_indexed 2025-11-14T08:41:49Z
format Journal Article
id curtin-20.500.11937-35550
institution Curtin University Malaysia
institution_category Local University
last_indexed 2025-11-14T08:41:49Z
publishDate 2008
publisher Wiley-Blackwell Publishing Asia
recordtype eprints
repository_type Digital Repository
spelling curtin-20.500.11937-355502017-09-13T15:25:36Z The prevalence of inherited thrombophilic polymorphisms in an asymptomatic Australian antenatal population Said, J. Brennecke, S. Moses, Eric Walker, S. Monagle, P. Campbell, J. Bryant, V. Borg, A. Higgins, J. Aim: Inherited thrombophilic polymorphisms have been linked to pregnancy-related thromboembolism and other adverse pregnancy outcomes. As there are limited data on the prevalence of these polymorphisms in Australian populations, we aimed to assess this in an antenatal population. Methods: Healthy nulliparous women (n=2031) were recruited to this study. The women had no past or family history of venous thromboembolism. Women were excluded if they or a family member was known to be a carrier of any thrombophilic marker. Genotyping from venous blood for the factor V Leiden, prothrombin 20210A, MTHFR 611 and 1298 and thrombomodulin C1418T polymorphisms was undertaken. Results: Key findings were that 101 of 2019 (5.30, 95% confidence interval 4.36-6.31%) women tested were heterozygous carriers of factor V Leiden and one was homozygous (0.05, 0-0.21%); 2.43% of women were heterozygous carriers of the prothrombin gene mutation (1.80-3.20%) while no women were homozygous for this mutation; 11.62% (10.22-13.02%) and 9.98% (8.61-11.29%) were homozygous for the MTHFR 611 and 1298 polymorphisms, respectively, and 3.43% (2.63-4.22%) of women were homozygous for the thrombomodulin polymorphism. Conclusions: The prevalence of these polymorphisms is consistent with previously published data in Caucasian populations. These data will provide the basis for further assessment of the relationship between poor pregnancy outcome and these inherited thrombophilic polymorphisms in an asymptomatic antenatal population. © 2008 The Royal Australian and New Zealand College of Obstetricians and Gynaecologists. 2008 Journal Article http://hdl.handle.net/20.500.11937/35550 10.1111/j.1479-828X.2008.00919.x Wiley-Blackwell Publishing Asia restricted
spellingShingle Said, J.
Brennecke, S.
Moses, Eric
Walker, S.
Monagle, P.
Campbell, J.
Bryant, V.
Borg, A.
Higgins, J.
The prevalence of inherited thrombophilic polymorphisms in an asymptomatic Australian antenatal population
title The prevalence of inherited thrombophilic polymorphisms in an asymptomatic Australian antenatal population
title_full The prevalence of inherited thrombophilic polymorphisms in an asymptomatic Australian antenatal population
title_fullStr The prevalence of inherited thrombophilic polymorphisms in an asymptomatic Australian antenatal population
title_full_unstemmed The prevalence of inherited thrombophilic polymorphisms in an asymptomatic Australian antenatal population
title_short The prevalence of inherited thrombophilic polymorphisms in an asymptomatic Australian antenatal population
title_sort prevalence of inherited thrombophilic polymorphisms in an asymptomatic australian antenatal population
url http://hdl.handle.net/20.500.11937/35550